Workflow
WSJ
icon
搜索文档
Week Ahead for FX, Bonds to Jan. 2: U.S. Data in Focus in Quiet Holiday Period
WSJ· 2025-12-19 17:09
Focus will center on a smattering of U.S. data releases, particularly GDP, as investors gauge the performance of the U.S. economy. ...
What Christmas Tree Sales Tell Us About Holiday Spending
WSJ· 2025-12-19 17:00
The needles are pointing to a more cautious consumer this year. ...
Krispy Kreme to Sell Japan Operations for $65 Million Proceeds
WSJ· 2025-12-19 16:46
Krispy Kreme has signed a deal to sell its operations in Japan to private-equity firm Unison Capital for cash proceeds of about $65 million, which the doughnut maker will use to pare its debt load. ...
Eurozone Consumer Confidence Weakens in December
WSJ· 2025-12-19 16:12
Eurozone consumer sentiment unexpectedly weakened in December despite cooling inflation and economic resilience against tariffs, a monthly indicator showed. ...
U.S. Labor Market Softened in October, November
WSJ· 2025-12-19 15:58
The Conference Board's Employment Trends Index declined to 105.80 in a joint number for both months, fueling further concerns about hiring after the unemployment rate edged higher. ...
Consumer Sentiment Rose in December But Remains Dim, Michigan Survey Suggests
WSJ· 2025-12-19 15:32
The University of Michigan's monthly survey's headline index rose to 52.9 this month, from 51 in November. ...
Home Sales Rose in November for the Third Consecutive Month
WSJ· 2025-12-19 15:01
Sales hit their highest level since February, after lower mortgage rates injected some fresh momentum into the long sluggish housing market. ...
Lamb Weston Swings to Profit as Revenue Ticks Up
WSJ· 2025-12-19 14:35
公司业绩表现 - 公司最新季度实现扭亏为盈 [1] - 公司最新季度收入实现小幅增长 [1]
Union Pacific, Norfolk Southern File for Merger Approval From Surface Transportation Board
WSJ· 2025-12-19 13:32
Union Pacific and Norfolk Southern filed an application with the Surface Transportation Board requesting approval of their proposed merger. ...
BioMarin to Buy Amicus Therapeutics for $4.8 Billion
WSJ· 2025-12-19 13:13
BioMarin Pharmaceutical has struck a deal to buy fellow biotechnology company Amicus Therapeutics for about $4.8 billion in cash. ...